This trial is active, not recruiting.

Condition breast cancer
Treatment adriamycin, taxol and cytoxan
Sponsor King Faisal Specialist Hospital & Research Center
Start date September 2007
End date September 2012
Trial size 100 participants
Trial identifier NCT00538395, RAC #981-020


Intensive sequential chemotherapy with Adriamycin Taxol and Cytoxan in the treatment of locally advanced breast cancer

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose treatment

Primary Outcomes

time frame: overall

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Patients with locally advanced breast cancer

Additional Information

Principal investigator Adnan Ezzat, MD
Trial information was received from ClinicalTrials.gov and was last updated in December 2011.
Information provided to ClinicalTrials.gov by King Faisal Specialist Hospital & Research Center.